Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05389774

DOLCE: Determining the Impact of Optellum's Lung Cancer Prediction Solution

DOLCE: Determining the Impact of Optellum's Lung Cancer Prediction (LCP) Artificial Intelligence Solution on Service Utilisation, Health Economics and Patient Outcomes

Status
Recruiting
Phase
Study type
Observational
Enrollment
2,000 (estimated)
Sponsor
Nottingham University Hospitals NHS Trust · Academic / Other
Sex
All
Age
35 Years
Healthy volunteers
Not accepted

Summary

This study is a multi-centre prospective observational cohort study recruiting patients with 5-30mm solid and part-solid pulmonary nodules that have been detected on CT chest scans performed as part of routine practice. The aim is to determine whether physician decision making with the AI-based LCP tool, generates clinical and health-economic benefits over the current standard of care of these patients.

Conditions

Timeline

Start date
2023-03-23
Primary completion
2025-08-01
Completion
2025-08-01
First posted
2022-05-25
Last updated
2025-04-08

Locations

10 sites across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT05389774. Inclusion in this directory is not an endorsement.